| Syphilis Diagnosis and Treatment | Lifetime | 31 | US 21 | 99.01 |
| HIV, Drug Use, Sexual Risk | Lifetime | 80 | US 45 | 99.39 |
| Sex work and related issues | Lifetime | 51 | US 31 | 99.19 |
| HIV/AIDS Research and Interventions | Lifetime | 216 | US 133 | 99.36 |
| Adolescent Sexual and Reproductive Health | Lifetime | 316 | US 203 | 98.36 |
| Reproductive tract infections research | Lifetime | 534 | US 274 | 96.26 |
| Biomedical and Engineering Education | Lifetime | 264 | US 161 | 92.80 |
| COVID-19 Impact on Reproduction | Lifetime | 577 | US 236 | 90.15 |
| Ethics in Clinical Research | Lifetime | 701 | US 373 | 91.60 |
| Social Media in Health Education | Lifetime | 453 | US 244 | 88.96 |
| Sexuality, Behavior, and Technology | Lifetime | 827 | US 425 | 91.53 |
| Global Health and Surgery | Lifetime | 521 | US 217 | 88.15 |
| Mobile Crowdsensing and Crowdsourcing | Lifetime | 911 | US 292 | 84.29 |
| Open Source Software Innovations | Lifetime | 954 | US 311 | 82.61 |
| Historical Medical Research and Treatments | Lifetime | 343 | US 158 | 74.45 |
| Healthcare Systems and Challenges | Lifetime | 563 | US 94 | 71.11 |
| Conferences and Exhibitions Management | Lifetime | 478 | US 125 | 58.89 |
| China's Global Influence and Migration | Lifetime | 352 | US 37 | 59.63 |
| Focus Groups and Qualitative Methods | Lifetime | 690 | US 294 | 36.23 |
| COVID-19 Digital Contact Tracing | Lifetime | 941 | US 216 | 31.67 |
| HIV/AIDS Research and Interventions | 2021-2025 | 44 | US 22 | 99.15 |
| HIV, Drug Use, Sexual Risk | 2021-2025 | 105 | US 54 | 97.55 |
| Adolescent Sexual and Reproductive Health | 2021-2025 | 95 | US 31 | 96.93 |
| HIV Research and Treatment | 2021-2025 | 187 | US 87 | 95.65 |
| Sex work and related issues | 2021-2025 | 90 | US 41 | 92.96 |
| Syphilis Diagnosis and Treatment | 2021-2025 | 75 | US 33 | 93.51 |
| Hepatitis C virus research | 2021-2025 | 513 | US 102 | 92.33 |
| Mobile Health and mHealth Applications | 2021-2025 | 497 | US 147 | 89.10 |
| Hepatitis B Virus Studies | 2021-2025 | 860 | US 181 | 88.40 |
| HIV/AIDS drug development and treatment | 2021-2025 | 809 | US 266 | 83.76 |
| Social Media in Health Education | 2021-2025 | 300 | US 129 | 78.55 |
| Reproductive tract infections research | 2021-2025 | 646 | US 221 | 80.27 |
| HIV/AIDS Impact and Responses | 2021-2025 | 275 | US 63 | 71.78 |
| Biomedical and Engineering Education | 2021-2025 | 376 | US 137 | 71.55 |
| Mental Health and Patient Involvement | 2021-2025 | 983 | US 141 | 70.67 |
| Global Health and Surgery | 2021-2025 | 859 | US 277 | 61.10 |
| Female Genital Mutilation/Cutting Issues | 2021-2025 | 326 | US 129 | 59.45 |
| Innovative Approaches in Technology and Social Development | 2021-2025 | 761 | US 64 | 53.43 |
| ICT in Developing Communities | 2021-2025 | 406 | US 110 | 43.28 |
| African Sexualities and LGBTQ+ Issues | 2021-2025 | 250 | US 85 | 33.52 |
| Focus Groups and Qualitative Methods | 2021-2025 | 100 | US 39 | 33.81 |
| Participatory Visual Research Methods | 2021-2025 | 527 | US 148 | 27.25 |
| COVID-19 Digital Contact Tracing | 2021-2025 | 777 | US 174 | 11.98 |
